FDA 483 - Sanjeev Puri, Clinical Investigator - December 14, 2018

An FDA inspection of Sanjeev Puri, Clinical Investigator, in Rock Island, IL, revealed significant deficiencies in clinical trial conduct. The inspection found failures to maintain adequate case histories, specifically regarding physical examination documentation, and a lack of adherence to the investigational plan, including the failure to report adverse events for study subjects.